NEW PRODUCT: COGNIVAID™
Moleac has just launched a new product, CognivAiD™, in Singapore!
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries to The Possible.
A growing international network
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
NEW STUDY SHEDS LIGHT ON THE RECOVERY PATHS OF SPORTS-RELATED VS. NON-SPORTS-RELATED TBIS
CLINICAL STUDY HIGHLIGHTS – Contrasting Characteristics and Outcomes of Sports-Related and Non–Sports-Related Traumatic Brain Injury by Michail Ntikas et al.
PREVENTION AND RECOVERY INSIGHTS FOR BRAIN INJURY AWARENESS MONTH
Brain Injury Awareness Month! Do you know the primary causes of traumatic brain injuries (TBIs)?
RECONNECTING LIVES: CELEBRATING PROGRESS DURING BRAIN INJURY AWARENESS MONTH WITH MOLEAC
In the recovery phase after a traumatic brain injury, every small victory is a triumph.